AI powered expansion EVERSANA is actively expanding its AI-powered commercialization platform with expanded capabilities across medical information, market research, MLR automation, and analytics, plus strategic partnerships to deploy AI solutions for US commercial teams.

Strategic partnerships Recent and notable partnerships with Pulse Infoframe for real-world evidence and with Lundbeck to deploy AI Agency across US commercial operations indicate a strong emphasis on integrated data-driven solutions and cross-functional collaboration opportunities.

Market access leadership Hiring seasoned market access leadership and focusing on navigating complex payer landscapes signals opportunities to pair EVERSANA’s services with payer strategy, pricing, and access programs for new and existing launches.

High growth potential With revenue in the broad B to B life sciences services space and a large client base including startups and established firms, EVERSANA presents new sales opportunities in early-phase and growth-stage companies seeking modern commercialization support.

Global reach footprint A diverse portfolio across US and international markets, combined with a robust tech stack and 650+ clients, suggests opportunities to offer end-to-end global commercialization solutions, including multi-market access and real-world evidence implementations.